Log in
Enquire now

List of Proclara Biosciences patents

List of Proclara Biosciences patents
List of Rgf Environmental Group, Inc patents
List of Celera Corporation patents
List of GKN patents
List of companies in 5AM Ventures's investment portfolio
List of funding rounds for Inkling
Patents where
Current Assignee
Name
is
Proclara BiosciencesProclara Biosciences
Name
Description
Patent Applicant
Current Assignee
Inventor
Patent Jurisdiction
Patent Number
Date of Patent
‌
US Patent 9988444 Polypeptides comprising a modified bacteriophage g3p amino acid sequence with reduced immunogenicity

Patent 9988444 was granted and assigned to Proclara Biosciences on June, 2018 by the United States Patent and Trademark Office.

Proclara Biosciences
Proclara Biosciences
Proclara Biosciences
Proclara Biosciences
United States Patent and Trademark Office
United States Patent and Trademark Office
9988444
June 5, 2018
‌
US Patent 9493515 Bacteriophage gene 3 protein compositions and use as amyloid binding agents

Patent 9493515 was granted and assigned to Proclara Biosciences on November, 2016 by the United States Patent and Trademark Office.

Proclara Biosciences
Proclara Biosciences
Proclara Biosciences
Proclara Biosciences
United States Patent and Trademark Office
United States Patent and Trademark Office
9493515
November 15, 2016
‌
US Patent 9688728 Bacteriophage gene 3 protein compositions and use as amyloid binding agents

Patent 9688728 was granted and assigned to Proclara Biosciences on June, 2017 by the United States Patent and Trademark Office.

Proclara Biosciences
Proclara Biosciences
Proclara Biosciences
Proclara Biosciences
United States Patent and Trademark Office
United States Patent and Trademark Office
9688728
June 27, 2017
‌
US Patent 10526377 Fusion proteins comprising P3 of bacteriophage

Patent 10526377 was granted and assigned to Proclara Biosciences on January, 2020 by the United States Patent and Trademark Office.

Proclara Biosciences
Proclara Biosciences
Proclara Biosciences
Proclara Biosciences
United States Patent and Trademark Office
United States Patent and Trademark Office
10526377
January 7, 2020
‌
US Patent 9493516 Bacteriophage gene 3 protein compositions and use as amyloid binding agents

Patent 9493516 was granted and assigned to Proclara Biosciences on November, 2016 by the United States Patent and Trademark Office.

Proclara Biosciences
Proclara Biosciences
Proclara Biosciences
Proclara Biosciences
United States Patent and Trademark Office
United States Patent and Trademark Office
9493516
November 15, 2016
‌
US Patent 10208090 Fusion proteins comprising P3 of bacteriophage

Patent 10208090 was granted and assigned to Proclara Biosciences on February, 2019 by the United States Patent and Trademark Office.

Proclara Biosciences
Proclara Biosciences
Proclara Biosciences
Proclara Biosciences
United States Patent and Trademark Office
United States Patent and Trademark Office
10208090
February 19, 2019
‌
US Patent 10151762 Bacteriophage gene 3 protein compositions and use as amyloid binding agents

Patent 10151762 was granted and assigned to Proclara Biosciences on December, 2018 by the United States Patent and Trademark Office.

Proclara Biosciences
Proclara Biosciences
Proclara Biosciences
Proclara Biosciences
United States Patent and Trademark Office
United States Patent and Trademark Office
10151762
December 11, 2018
‌
US Patent 10722551 Polypeptides comprising a modified bacteriophage G3P amino acid sequence lacking a glycosylation signal

Proclara Biosciences
Proclara Biosciences
Proclara Biosciences
Proclara Biosciences
United States Patent and Trademark Office
United States Patent and Trademark Office
10722551
July 28, 2020
8 results
0 selected
8 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us